Ferrokin Biosciences Inc. develops and markets medical devices. The company offers iron chelator for the treatment of iron-overload in patients with transfusion-dependent hereditary and acquired refractory anemias.
The company is based in San Carlos, California.
Funding Rounds (3) - $30MUpdate
|Mar 13, 2014||SEC - SEC FORM D/A|
|Sep 2, 2013||SEC - SEC FORM D|
|Mar 15, 2012||PRNewswire All - Shire to Acquire FerroKin BioSciences, Inc., and its Phase 2 Iron Chelator Treatment|
|Jun 20, 2010||Fierce Biotech - FerroKin Biosciences raises 12000000 in venture round|
|Dec 5, 2008||OnBioVC - FerroKin Biosciences, Inc.: Series A $15|
300 Shire Way
Lexington, Massachusetts 02421